BACH1 and Parkinson disease: Indeed, upregulated BACH1 levels have been reported in post-mortem PD brains as well as in preclinical disease models and further associated with repression of the expression of NRF2 protective genes (Zhou et al., 2018; Ahuja et al., 2021).